Biogen lures Merck exec to post of CCO

US biotech major Biogen (Nasdaq: BIIB) has recruited former Merck & Co executive Michel Vounatsos as the company’s executive vice president and chief commercial officer, effective April 18, 2016.

Mr Vounatsos will oversee the development and execution of Biogen’s global commercial strategy, with a focus on the continued growth of Biogen’s product portfolio and the development of the commercial infrastructure and approach to support the company’s key pipeline assets. He will report to George Scangos, chief executive, and will be a member of the Biogen management team.

“Michel is a sophisticated global business leader who brings a track record of commercial success and creativity to Biogen,” said Dr Scangos, adding: “As the complexity of our business and the expectations of our stakeholders accelerate, Michel will play a critical role in driving our near-term growth while helping prepare our organization to support our increasingly robust and diverse pipeline.”